documents: FDA-2006-N-0515-0091
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2006-N-0515-0091 | FDA | FDA-2006-N-0515 | Reference 4 Evaluation of How Best to Communicate with Healthcare Providers about the Risks and Benefits of Prescription Drug Use for Pregnant and Nursing Women A Mental Models Research Report Final Report re Ref2 Final Regulatory Impact Analysis for Docket No. FDA-2006-N-0515 (formerly Docket No. 2006N-0467) | Supporting & Related Material | Background Material | 2014-12-30T05:00:00Z | 2014 | 12 | 2014-12-30T18:22:18Z | 0 | 0 | 090000648199a463 |
Links from other tables
- 0 rows from regs_document_id in fr_regs_crossref